INDIANA — As COVID-19 transmission increases across the United States, in at least 45 states. Public health officials are raising concerns about potential obstacles to vaccination this fall, particularly for young children.

While Indiana’s percentage of emergency department visits for COVID-19 remains low, the Indiana epidemic trend is categorized as “growing,” with a 99.68% probability of continued spread.
The U.S. Centers for Disease Control and Prevention (CDC) has warned state and local health officials that the U.S. Food and Drug Administration (FDA) may not re-authorize the Pfizer-BioNTech COVID-19 vaccine for children younger than five. This age group is considered the most vulnerable to severe illness from the virus. If authorization is not renewed, the Pfizer vaccine would become unavailable for this demographic.
The other available option for healthy children under five, Moderna’s COVID-19 vaccine, would have to be administered “off-label” by a willing pharmacist or physician, creating another significant hurdle. The uncertainty for young children follows a May announcement by HHS Secretary Robert F. Kennedy Jr. that the CDC would no longer recommend COVID-19 vaccines for healthy children or pregnant women.
Furthermore, the FDA has not yet approved the formulations for either the COVID-19 or flu vaccines for the upcoming 2025-2026 season for adults. This regulatory delay could impact the public’s ability to get vaccinated promptly as the virus begins to circulate more widely.
Despite the low percentage of COVID-19-related emergency department visits in Indiana (currently at 0.44%), the state’s epidemic trend is officially growing. The Rt Estimate, which measures the average number of people an infected person passes the virus to, is at 1.21, indicating that the virus is spreading.
This combination of rising national transmission rates and potential logistical and regulatory challenges for vaccine access has created a complex public health landscape heading into the fall season. Public health experts continue to emphasize the importance of vaccination as a key tool in preventing severe illness and hospitalization from COVID-19.


